Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

September 15, 2022

Hopkinton bioscience company forms advisory board for cell and gene therapy

Courtesy | Lykan Bioscience Lykan Bioscience is a privately held cell-based therapies contract manufacturing services organization located in Hopkinton.

Two bioscience companies, including one based in Hopkinton, have formed a scientific advisory board to provide insight in development and manufacturing of advanced therapies. 

Lykan Bioscience, a cell-based therapies contract development and manufacturing services provider based in Hopkinton, has partnered with RoslinCT of the United Kingdom to develop a scientific advisory board comprised of pioneers in the cell and gene therapy spaces. 

The board will work closely with members of the management teams of both companies to provide insight into a wide range of topics across the development and manufacturing of advanced therapies, according to a Tuesday press release from the companies. 

Members include Michael Chambers, cofounder of North Dakota-based Aldevron; Heidi Hagen, chief technology officer at Sonoma Biotherapeutics in California and Washington; Margit Jeschke, an independent consultant and expert on the analytical development strategy for cell and gene therapy; and Michael Kalos, founder and managing director at Next Pillar Consulting, LLC in Pennsylvania.

Sign up for Enews

WBJ Web Partners


Order a PDF